Sign in
Sign in
Recover your password.
A password will be e-mailed to you.
Ideal Cures receives EXCiPACT certification for 3rd manufacturing site
With receipt of this third certificate all manufacturing plants of Ideal Cures located in India at Vasai, Jammu and Khambhat are…
DRL unveils new corporate brand identity
The new identity speaks of Dr Reddy’s constant endeavour to understand the unmet and under-met needs of patients, and the swift…
Lonza announces additional long-term agreement with Alexion
This agreement will supplement existing production of Alexion products at multiple Lonza facilities
Lubrizol to organise third Carbopol workshop on topical formulations
Lubrizol LifeSciences is organising its third carbopol workshop on topical formulations on July 8 at its application and training…
3rd Carbopol workshop – Topical formulations
The workshop has been designed to impart comprehensive theoretical as well as practical hands-on knowledge about using various…
Suven gets three product patents in Israel, Japan and South Africa
Patents are for the treatment of disorders associated with neuro-degenerative diseases
Hilleman Laboratories’ preclinical trial report on Hib vaccine offers hope to millions of children
The unique formulation will not only be cost effective but also scalable for commercial manufacturing
Global vaccine research and…
New data fuel hopes for broad use of Novartis psoriasis drug
Novartis is increasingly confident about the potential of its new injectable drug Cosentyx, as fresh clinical data confirms its…
Dr Reddy’s Laboratories recalls anti-seizure, hypertension drugs from US market
Dr Reddy's Laboratories has started recalling Divalproex Sodium extended-release tablets as it has failed dissolution tests, and…
TRIPs-ing time again
When governments have to weigh public health against IP issues, LDCs and developing countries really have no choice but to plug…